MRMD
insider transactionsMARIMED INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+100.0K
100.0K buy · 0 sell
Net value · 90d
$7.5K
$7.5K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
4
100.0K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Commercial Officer
$0
250.0K sh
Own +50%
-
Other·F
Chief Commercial Officer
$6.0K
86.6K sh · $0.07
Own -7%
-
Exercise·M
Chief Commercial Officer
$0
250.0K sh
Own +27%
-
Exercise·M
Director
$0
75.0K sh
Own New
-
Exercise·M
Director
$0
75.0K sh
Own +16%
-
Exercise·M
Director
$0
75.0K sh
Own New
-
Exercise·M
Director
$0
75.0K sh
Own +8%
-
Exercise·M
Director
$0
75.0K sh
Own New
-
Exercise·M
Director
$0
75.0K sh
Own +16%
-
Exercise·M
Chief Commercial Officer
$0
54.0K sh
Own New
-
Other·F
Chief Commercial Officer
$1.4K
18.7K sh · $0.08
Own -2%
-
Exercise·M
Chief Commercial Officer
$0
54.0K sh
Own +6%
-
Grant·A
Director
$0
75.0K sh
Own New
-
Grant·A
Director
$0
75.0K sh
Own New
-
Grant·A
Director
$0
75.0K sh
Own New
-
Exercise·M
Chief Operating Officer
$0
40.6K sh
Own +50%
-
Other·F
Chief Operating Officer
$1.1K
14.1K sh · $0.08
Own -0%
-
Exercise·M
Chief Operating Officer
$0
40.6K sh
Own +0%
-
Exercise·M
Jon R Levine KEY
President and CEO
$0
46.9K sh
Own +50%
-
Other·F
Jon R Levine KEY
President and CEO
$1.3K
16.2K sh · $0.08
Own -0%
-
Exercise·M
Jon R Levine KEY
President and CEO
$0
46.9K sh
Own +0%
-
Exercise·M
Chief Commercial Officer
$0
37.5K sh
Own +50%
-
Other·F
Chief Commercial Officer
$1.0K
13.0K sh · $0.08
Own -1%
-
Exercise·M
Chief Commercial Officer
$0
37.5K sh
Own +4%
-
Buy·P
Jon R Levine KEY
President and CEO
$1.5K
20.0K sh · $0.07
Own +0%
-
Buy·P
Jon R Levine KEY
President and CEO
$2.8K
37.0K sh · $0.08
Own +0%
-
Buy·P
Jon R Levine KEY
President and CEO
$230
3.0K sh · $0.08
Own +0%
-
Buy·P
Jon R Levine KEY
President and CEO
$3.0K
40.0K sh · $0.08
Own +0%
-
Exercise·M
Jon R Levine KEY
President and CEO
$0
75.0K sh
Own New
-
Other·F
Jon R Levine KEY
President and CEO
$2.3K
26.0K sh · $0.09
Own -0%
-
Exercise·M
Jon R Levine KEY
President and CEO
$0
75.0K sh
Own +0%
-
Grant·A
Chief Operating Officer
$0
170.6K sh
Own New
-
Grant·A
Mario Pinho KEY
Chief Financial Officer
$0
153.1K sh
Own New
-
Grant·A
Jon R Levine KEY
President and CEO
$0
122.5K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
131.2K sh
Own New
-
Exercise·M
Chief Operating Officer
$0
10.0K sh
Own +100%
-
Other·F
Chief Operating Officer
$239
3.5K sh · $0.07
Own -0%
-
Exercise·M
Chief Operating Officer
$0
10.0K sh
Own +0%
-
Exercise·M
Jon R Levine KEY
President and CEO
$0
11.5K sh
Own +100%
-
Other·F
Jon R Levine KEY
President and CEO
$276
4.0K sh · $0.07
Own -0%
-
Exercise·M
Jon R Levine KEY
President and CEO
$0
11.5K sh
Own +0%
-
Exercise·M
Chief Commercial Officer
$0
6.0K sh
Own +100%
-
Other·F
Chief Commercial Officer
$159
2.1K sh · $0.08
Own -0%
-
Exercise·M
Chief Commercial Officer
$0
6.0K sh
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Ryan Crandall | Exercise M | 250.0K | $0 |
| Jun 15, 2026 | Ryan Crandall | Other F | 86.6K | $6.0K |
| Jun 15, 2026 | Ryan Crandall | Exercise M | 250.0K | $0 |
| Jun 12, 2026 | Eva Selhub M.D. | Exercise M | 75.0K | $0 |
| Jun 12, 2026 | Eva Selhub M.D. | Exercise M | 75.0K | $0 |
| Jun 12, 2026 | Edward J Gildea | Exercise M | 75.0K | $0 |
| Jun 12, 2026 | Edward J Gildea | Exercise M | 75.0K | $0 |
| Jun 12, 2026 | David R Allen | Exercise M | 75.0K | $0 |
| Jun 12, 2026 | David R Allen | Exercise M | 75.0K | $0 |
| Jun 8, 2026 | Ryan Crandall | Exercise M | 54.0K | $0 |
| Jun 8, 2026 | Ryan Crandall | Other F | 18.7K | $1.4K |
| Jun 8, 2026 | Ryan Crandall | Exercise M | 54.0K | $0 |
| Jun 4, 2026 | Eva Selhub M.D. | Grant A | 75.0K | $0 |
| Jun 4, 2026 | Edward J Gildea | Grant A | 75.0K | $0 |
| Jun 4, 2026 | David R Allen | Grant A | 75.0K | $0 |
| May 29, 2026 | Timothy Shaw | Exercise M | 40.6K | $0 |
| May 29, 2026 | Timothy Shaw | Other F | 14.1K | $1.1K |
| May 29, 2026 | Timothy Shaw | Exercise M | 40.6K | $0 |
| May 29, 2026 | Jon R Levine KEY | Exercise M | 46.9K | $0 |
| May 29, 2026 | Jon R Levine KEY | Other F | 16.2K | $1.3K |
| May 29, 2026 | Jon R Levine KEY | Exercise M | 46.9K | $0 |
| May 29, 2026 | Ryan Crandall | Exercise M | 37.5K | $0 |
| May 29, 2026 | Ryan Crandall | Other F | 13.0K | $1.0K |
| May 29, 2026 | Ryan Crandall | Exercise M | 37.5K | $0 |
| May 22, 2026 | Jon R Levine KEY | Buy P | 20.0K | $1.5K |
| May 22, 2026 | Jon R Levine KEY | Buy P | 37.0K | $2.8K |
| May 22, 2026 | Jon R Levine KEY | Buy P | 3.0K | $230 |
| May 20, 2026 | Jon R Levine KEY | Buy P | 40.0K | $3.0K |
| May 7, 2026 | Jon R Levine KEY | Exercise M | 75.0K | $0 |
| May 7, 2026 | Jon R Levine KEY | Other F | 26.0K | $2.3K |
| May 7, 2026 | Jon R Levine KEY | Exercise M | 75.0K | $0 |
| Apr 15, 2026 | Timothy Shaw | Grant A | 170.6K | $0 |
| Apr 15, 2026 | Mario Pinho KEY | Grant A | 153.1K | $0 |
| Apr 15, 2026 | Jon R Levine KEY | Grant A | 122.5K | $0 |
| Apr 15, 2026 | Ryan Crandall | Grant A | 131.2K | $0 |
| Apr 2, 2026 | Timothy Shaw | Exercise M | 10.0K | $0 |
| Apr 2, 2026 | Timothy Shaw | Other F | 3.5K | $239 |
| Apr 2, 2026 | Timothy Shaw | Exercise M | 10.0K | $0 |
| Apr 2, 2026 | Jon R Levine KEY | Exercise M | 11.5K | $0 |
| Apr 2, 2026 | Jon R Levine KEY | Other F | 4.0K | $276 |
| Apr 2, 2026 | Jon R Levine KEY | Exercise M | 11.5K | $0 |
| Mar 28, 2026 | Ryan Crandall | Exercise M | 6.0K | $0 |
| Mar 28, 2026 | Ryan Crandall | Other F | 2.1K | $159 |
| Mar 28, 2026 | Ryan Crandall | Exercise M | 6.0K | $0 |
About MRMD insider trading
This page tracks insider transactions for MARIMED INC. (MRMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.